| RS1734858651 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Neural tube defects |
| RS1734860676 |
COQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Coenzyme Q10 deficiency, primary |
| RS1734884330 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1734887425 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1734890180 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1734927527 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1734931275 |
MTRR
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylcobalamin deficiency type cblE, Neural tube defects |
| RS1734954603 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1734957331 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1734966566 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1734986168 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1734988578 |
SDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1734990759 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 2, Van Maldergem syndrome 2 |
| RS1735002961 |
SDHA
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1735008495 |
COQ2
|
Health Risk |
Pathogenic |
Multiple system atrophy, Multiple system atrophy |
| RS1735081763 |
FAT4
|
Health Risk |
Likely pathogenic |
Van Maldergem syndrome 2, Van Maldergem syndrome 2 |
| RS1735116193 |
GRIA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with language impairment and behavioral abnormalities, Neurodevelopmental disorder with language impairment and behavioral abnormalities |
| RS1735288987 |
PLK4
|
Health Risk |
Pathogenic |
— |
| RS1735294501 |
GRIA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with language impairment and behavioral abnormalities, Neurodevelopmental disorder with language impairment and behavioral abnormalities |
| RS17352989 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Weill-Marchesani syndrome |
| RS1735303754 |
GRIA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with language impairment and behavioral abnormalities, Neurodevelopmental disorder with language impairment and behavioral abnormalities |
| RS1735304403 |
PLK4
|
Health Risk |
Likely pathogenic |
— |
| RS1735312842 |
HPGD
|
Health Risk |
Pathogenic |
— |
| RS1735328958 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS1735351912 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS1735353141 |
SDHA
|
Health Risk |
Likely pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS17354992 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myopathy |
| RS1735565649 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1735567359 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS1735626197 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, Deficiency of 3-hydroxyacyl-CoA dehydrogenase |
| RS1735642901 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1735691933 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1735710012 |
SDHA
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1GG, Pheochromocytoma/paraganglioma syndrome 5 |
| RS1735710103 |
SDHA
|
Health Risk |
Likely pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1735767573 |
TRAPPC11
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS1735779936 |
SDHA
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1735786455 |
OTULIN
|
Health Risk |
Pathogenic |
Autoinflammation, panniculitis |
| RS1735791499 |
SDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1735798915 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1735848896 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1735877322 |
TRAPPC11
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS1735893497 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS1735952327 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS1735963864 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, Hyperinsulinemic hypoglycemia |
| RS1735964758 |
HADH
|
Health Risk |
Likely pathogenic |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Deficiency of 3-hydroxyacyl-CoA dehydrogenase |
| RS1735999769 |
CYP4V2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bietti crystalline corneoretinal dystrophy, Bietti crystalline corneoretinal dystrophy |
| RS1736000365 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1736050138 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1736114396 |
HADH
|
Health Risk |
Likely pathogenic |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Deficiency of 3-hydroxyacyl-CoA dehydrogenase |
| RS1736178477 |
PDE6B
|
Health Risk |
Likely pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1736201319 |
HPGD
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS1736209 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial spontaneous pneumothorax, Birt-Hogg-Dube syndrome |
| RS1736225856 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1736296921 |
CYP4V2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1736302165 |
CYP4V2
|
Health Risk |
Likely pathogenic |
— |
| RS1736332381 |
MFSD8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1736332603 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1736334634 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1736337186 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Hyperinsulinemic hypoglycemia |
| RS1736337431 |
HADH
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Hyperinsulinemic hypoglycemia |
| RS1736344235 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1736367074 |
NEK1
|
Health Risk |
Likely pathogenic |
NEK1-related disorder, NEK1-related disorder |
| RS1736369601 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1736400607 |
MFSD8
|
Health Risk |
Likely pathogenic |
— |
| RS1736402440 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS1736404481 |
PDE6B
|
Health Risk |
Pathogenic |
— |
| RS1736425011 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 40 |
| RS1736426982 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 40 |
| RS1736442342 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS1736569883 |
GRIA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with language impairment and behavioral abnormalities, Neurodevelopmental disorder with language impairment and behavioral abnormalities |
| RS1736606187 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1736631406 |
CYP4V2
|
Health Risk |
Pathogenic |
— |
| RS1736641565 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1736679814 |
CYP4V2
|
Health Risk |
Likely pathogenic |
— |
| RS1736687730 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1736795573 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1736797211 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1736840999 |
TRIO
|
Health Risk |
Pathogenic/Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS1736861131 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1736926873 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1736928101 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1736930552 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1736934298 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1736947312 |
PDE6B
|
Health Risk |
Pathogenic |
— |
| RS1736955435 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1736958050 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1737048333 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS1737110583 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1737147925 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS1737148739 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1737176330 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS1737195067 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1737204592 |
SGCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy |
| RS1737229618 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 40 |
| RS1737230745 |
NSUN2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 5 |
| RS1737305761 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS1737312210 |
PDE6B
|
Health Risk |
Pathogenic |
— |
| RS1737315492 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 40, Retinal dystrophy |
| RS1737323722 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS1737428529 |
PDE6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |